This inventor holds 2 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 2003-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2007
Title: Inventor Snehlata S Mascarenhas: Pioneering Pharmaceutical Innovations
Introduction
Snehlata S Mascarenhas is an accomplished inventor based in Indianapolis, IN, known for her significant contributions to the field of pharmaceuticals. With a total of two patents to her name, she is recognized for her innovative work that enhances drug formulation and delivery. Currently, she is employed at Eli Lilly and Company, a leading global healthcare company committed to creating medicines that help people live longer, healthier lives.
Latest Patents
Her latest patents include formulations that focus on 2-methyl-thieno-benzodiazepine. The first patent details a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine, olanzapine pamoate, or their solvates. Furthermore, this invention introduces novel olanzapine pamoate salts or solvates. The second patent reiterates the same innovative approach, highlighting the importance of the formulation technique and its implications in therapeutic applications.
Career Highlights
Snehlata's career at Eli Lilly and Company has been marked by her dedication to research and development in drug formulation. Her work has contributed significantly to enhancing the efficacy and delivery of pharmaceutical compounds. Through her research, she continues to push the boundaries of innovation in the pharmaceutical sector.
Collaborations
During her tenure at Eli Lilly, Snehlata has collaborated with several esteemed colleagues, including Douglas J Allen and Kurt D Dekemper. These collaborations have fostered a dynamic environment of shared knowledge and expertise, leading to advancements in pharmaceutical formulations and innovations in drug delivery systems.
Conclusion
In conclusion, Snehlata S Mascarenhas stands out as a prominent figure in the realm of pharmaceutical innovations. Her patents reflect her dedication to improving drug delivery mechanisms and highlight her contributions to a healthier society through her work at Eli Lilly and Company. The impact of her innovations is sure to resonate within the industry for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile